Report: Pfizer Wants to Buy AstraZeneca for $101B

View Comments (
)
|
Email
|
Print

    NEWSLETTERS

    Getty Images

    Two Big Pharma companies with strong ties to the Philadelphia region are the subject of the latest mega-merger rumor in the drug manufacturing industry.

    Pfizer Inc. has expressed an interest in acquiring AstraZeneca for $101 billion, according to a  report in London's Sunday Times. The two companies declined commenting on the report.

    The Times report said the companies have had informal discussions about a deal, but AstraZeneca officials were not receptive to the overture.

    The acquisition would give Pfizer access to AstraZeneca's pipeline of experimental cancer treatments, an category in which Pfizer is looking to expand and has several new drug candidates. Read more about this story on PBJ.com.

    For more breaking business news go to PBJ.com